Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea.
Ji Yeon LeeSeon Hee BuEunHyang SongSeongcheol ChoSungbong YuJungok KimSungmin KimKwang Won SeoKi Tae KwonJin Yong KimSung Hyun KimKeum Young AhnNahyun JungYeonmi LeeYoobin JungChankyoung HwangWan Beom ParkPublished in: Infectious diseases and therapy (2023)
This large-scale PMS study demonstrated that regdanvimab was effective against COVID-19 progression and had an acceptable safety profile when used in real-world clinical practice.